| abstract |
The present invention relates to indole benzylamine compounds useful as tryptase inhibitors. Furthermore, the invention relates to the use of a compound for treating a patient suffering from or susceptible to a physiological condition in need of improvement by inhibition of tryptase, comprising administering to the patient a therapeutically effective amount of the compound. To do. The present invention further relates to pharmaceutical compositions comprising a therapeutically effective amount of a compound of formula I and a pharmaceutically acceptable carrier. [Chemical 1] |